Watermark
  Back to Search Results

BGB-290-103

Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-290-103

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03150810

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2017-001553-14

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan